Impact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions

Marcel Nogueira

Authors

Marcel Nogueira

Keywords:

Abstract

Abstract not found

Downloads

How to Cite

Impact of Pharmacist Interventions on Direct-Acting Antivirals Sustained Virologic Responde and Drug-Drug Interactions. (2020). Global Journal of Medical Research, 20(B3), 15-20. https://medicalresearchjournal.org/index.php/GJMR/article/view/2008

Download Citation

References

Jeffrey Stanaway, Abraham Flaxman, Mohsen Naghavi, Christina Fitzmaurice, Theo Vos, Ibrahim Abubakar, Laith Abu-Raddad, Reza Assadi, Neeraj Bhala, Benjamin Cowie, Mohammad Forouzanfour, Justina Groeger, Khayriyyah Hanafiah, Kathryn Jacobsen, Spencer James, Jennifer Maclachlan, Reza Malekzadeh, Natasha Martin, Ali Mokdad, Ali Mokdad, Christopher Murray, Dietrich Plass, Saleem Rana, David Rein, Jan Richardus, Juan Sanabria, Mete Saylan, Saeid Shahraz, Samuel So, Vasiliy Vlassov, Elisabete Weiderpass, Steven Wiersma, Mustafa Younis, Chuanhua Yu, Maysaa El Sayed Zaki, Graham Cooke (2016) The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. 388(10049), 1081-1088.

E Gane, D Kershenobich, C Seguin-Devaux, Kristian Aho, I, Dalgard (2015) Strategies to manage hepatitis virus (HCV) infection disease burdenvolume 2. 22(Suppl 1), 46-73.

J Chhatwal, X Wang, T Ayer, M Kabiri, R Chung, C Hur (2016) Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals. 64, 1442-1450.

(2017) WHO Expert Committee on Drug Dependence: Twenty-eighth report..

Who (2016) Combating Hepatitis B and C to Reach Eliminationby.

B Maasoumy, K Port, Calle Serrano, B Markova, A Sollik, L Manns, M (2013) The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C. 38, 1365-1372.

Brasil Protocolo Clínico e Diretrizes Terapêuticas para o tratamento da hepatite viral crônica C e co-infecções.

Liverpool Uo (2017) HEP Drug Interactions.

Jean-Michel Pawlotsky, Francesco Negro, Alessio Aghemo, Marina Berenguer, Olav Dalgard, Geoffrey Dusheiko, Fiona Marra, Massimo Puoti, Heiner Wedemeyer (2018) EASL Recommendations on Treatment of Hepatitis C 2018. 69(2), 461-511.

Clara De Kanter, Joost Drenth, Joop Arends, Henk Reesink, Marc Van Der Valk, Robert De Knegt, David Burger (2014) Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations. 53(5), 409-427.

Tushar Garimella, Reena Wang, Wen-Lin Luo, Carey Hwang, Diane Sherman, Hamza Kandoussi, Thomas Marbury, Harry Alcorn, Richard Bertz, Marc Bifano (2015) Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment. 20(5), 535-543.

T Saussele, O Burk, J Blievernicht, K Klein, A Nussler, N Nussler (2007) Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole. 82, 265-274.

Timothy Gauthier, Eva Moreira, Chantal Chan, Alexandria Cabrera, Maribel Toro, Mara Carrasquillo, Mark Corentin, Elizabeth Sherman (2016) Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution. 56(6), 670-676.

R Abreu, Silva Da, C Ferreira, A Ferreira, E Remor, P Nasser, F Carrilho (2016) Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B. 5, 53-64.

J Langness, M Nguyen, A Wieland, G Everson, J Kiser (2017) Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions. 23, 1618-1626.

M Kooy, Ecg Van Geffen, E Heerdink, L Van Dijk, M Bouvy (2014) Effects of a Telephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial. 219.

A Ottman, M Townsend, M Hashem, V Dimondi, R Britt (2018) Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection. 1060028018766507.

Franz Faul, Edgar Erdfelder, Axel Buchner, Albert-Georg Lang (2009) Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. 41(4), 1149-1160.

H Cheinquer, H Sette, Jr Wolff, F De Araujo, A Coelho-Borges, S Soares, Srp (2017) Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil. 16, 727-733.

V Ferreira, Hhl Borba, A Wiens, Mla Pedroso, Vfc Radunz, Cap Ivantes (2018) Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases.

M Sulkowski, D Gardiner, M Rodriguez-Torres, K Reddy, T Hassanein, I Jacobson (2014) Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. 370, 211-221.

Elise Smolders, Floor Berden, Clara De Kanter, Wietske Kievit, Joost Drenth, David Burger (2017) The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug‐drug interactions. 5(5), 648-657.

Paulo Arrais, Maria Fernandes, Tatiane Pizzol, Luiz Ramos, Sotero Mengue, Vera Luiza, Noemia Tavares, Mareni Farias, Maria Oliveira, Andréa Bertoldi (2016) Prevalence of self-medication in Brazil and associated factors. 50(suppl 2), 13.